Concepedia

Miku Wada

MW

Statistics

Publications

3

Citations

78

H-Index

3

Active since

2019

Affiliations

The University of Tokyo(Current)

RIKEN Center for Advanced Intelligence Project

Miku Wada is an author at The University of Tokyo specializing in oncology, epigenetics, and molecular oncology.

Publications per year

2019–2022

3

Publications

3

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas

Asako Kukita, Kenbun Sone, Katsutoshi Oda et al. · Biochemical and Biophysical Research Communications · 2019 · 33 citations

, , +16

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

Miku Wada, Asako Kukita, Kenbun Sone et al. · Biomolecules · 2020 · 24 citations · Full text

, , +17

The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells

Asako Kukita, Kenbun Sone, Syuzo Kaneko et al. · Cancers · 2022 · 21 citations · Full text

, , +17

1–3 of 3